Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XNW28012 in Metastatic Pancreatic Cancer
NCT07823049Phase 3Recruiting
- Sponsor
- Evopoint Biosciences
- Start
- Jul 2025
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 3 trial of xnw28012 in pancreatic cancer (PC), sponsored by Evopoint Biosciences. Started Jul 2025; status: recruiting.
02
Drugs
xnw28012
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07823049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07823049.